Dilated cardiomyopathy (DCM) is one of the leading causes of heart failure worldwide. DCM
is defined as the dilatation and thinning of heart muscles leading to enlargement of the …

Risk stratification of patients with systolic chronic heart failure (HF) is critical to better identify
those who may benefit from invasive therapeutic strategies such as cardiac transplantation …

Heart failure (HF) development is characterized by huge structural changes that are crucial
for disease progression. Analysis of time dependent global proteomic adaptations during HF …

Highlights•The complex pathophysiology of heart failure is summarized.•This article reviews
the use of proteomics to elucidate responses to cardiac injury.•Proteomic analyses of tissue …

Acute decompensated heart failure (ADHF) is a life-threatening clinical syndrome involving
multi-organ function deterioration. ADHF results from multifaceted, dysregulated pathways …

The clinical association between atrial fibrillation (AF), coronary microvascular disease
(CMD) and heart failure with preserved ejection fraction (HFpEF) is highly prevalent …

Heart failure (HF) remains a common complication after acute ST‐segment elevation
myocardial infarction (STEMI). Here, we aim to identify critical genes related to the …

Methods Comparative extensive proteomic analysis of the myocardium was performed in
nine patients with biopsy-proven non-ischemic cardiomyopathies (3 dilated cardiomyopathy …

To identify potential biomarkers supporting better phenotyping and to improve
understanding of the pathophysiology of dilated cardiomyopathy (DCM), this study …

Circulating protein biomarkers provide information regarding pathways in heart failure (HF)
and can add important value to clinicians. Advancements in proteomics allow researchers to …